The need for more diversity in clinical trials is being increasingly emphasized, but more creative and collaborative recruitment approaches may be needed to make trials more diverse....
A new report by GlobalData previews the upcoming initiations and completions of clinical trials in the new year....
Professor Paul Hutson and collaborators in the Transdisciplinary Center for Research in Psychoactive Substances study psilocybin for opioid and methamphetamine use disorders....
Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new study, completing a “handshake” that may show the cells are ready for clinical trials....
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens....
While the use of digital health technologies has increased in clinical trials, securing patients' trust continues to be a significant challenge. These technologies may help build trust by helping to increase representation in clinical trials....
Clinical researchers and study teams around the globe have widely adopted technology solutions that will forever change how clinical trials are designed and conducted moving forward....
A study presented at the San Antonio Breast Cancer Symposium aimed to identify factors associated with patient preference for an initial consult via telemedicine and whether there was a correlation with clinical trial enrollment....
Wisconsin could be at the center of a regional medical physics hub that would be a catalyst for scientific breakthroughs and innovative companies that transform and extend human life....
